Replimune Group, Inc. (REPL) vs Y-mAbs Therapeutics, Inc. (YMAB)
Detailed comparison between Replimune Group, Inc., Y-mAbs Therapeutics, Inc..Total Return (%)
Replimune Group, Inc. (REPL)Y-mAbs Therapeutics, Inc. (YMAB)
Which stock do you think will perform better?
Replimune Group, Inc.
REPL
Y-mAbs Therapeutics, Inc.
YMAB
| Metric | Replimune Group, Inc. (REPL) | Y-mAbs Therapeutics, Inc. (YMAB) |
|---|---|---|
| Current Price | $12.50 | $4.32 |
| Change | -0.13 (-1.03%) | -0.03 (-0.69%) |
| Market Cap | $0.96B | $0.20B |
| Trailing P/E | 0.00 | 0.00 |
| Forward P/E | -4.65 | -7.45 |
| Dividend Yield | 0.00% | 0.00% |
| 52-Week High | $17.00 | $16.11 |
| 52-Week Low | $6.44 | $3.55 |
| Beta | 0.00 | 0.00 |
| Earnings Per Share | $-3.07 | $-0.64 |
Processing data. Please try again later.
Average Return
| Symbol | 1 Month | Year-to-date | 1 Year | 5 Years | 10 Years | Max |
|---|---|---|---|---|---|---|
| REPL | 34.84% | 5.49% | 26.39% | -44.32% | -17.55% | -17.55% |
| YMAB | -2.04% | -30.21% | -62.73% | -89.44% | -82.00% | -82.00% |